SMPDB ID,Pathway Name,Pathway Subject,Metabolite ID,Metabolite Name,HMDB ID,KEGG ID,ChEBI ID,DrugBank ID,CAS,Formula,IUPAC,SMILES,InChI,InChI Key
SMP0000642,Nevirapine Metabolism Pathway,Drug Metabolism,PW_C008780,Nevirapine,HMDB0014383,C07263,63613,DB00238,129618-40-2,C15H14N4O,"2-cyclopropyl-7-methyl-2,4,9,15-tetraazatricyclo[9.4.0.0³,⁸]pentadeca-1(11),3,5,7,12,14-hexaen-10-one",CC1=C2NC(=O)C3=C(N=CC=C3)N(C3CC3)C2=NC=C1,"InChI=1S/C15H14N4O/c1-9-6-8-17-14-12(9)18-15(20)11-3-2-7-16-13(11)19(14)10-4-5-10/h2-3,6-8,10H,4-5H2,1H3,(H,18,20)",NQDJXKOVJZTUJA-UHFFFAOYSA-N
SMP0000642,Nevirapine Metabolism Pathway,Drug Metabolism,PW_C008649,3-Hydroxynevirapine,HMDB0013914,,,"","",C15H14N4O2,"2-cyclopropyl-6-hydroxy-7-methyl-2,4,9,15-tetraazatricyclo[9.4.0.0³,⁸]pentadeca-1(11),3,5,7,12,14-hexaen-10-one",CC1=C2NC(=O)C3=C(N=CC=C3)N(C3CC3)C2=NC=C1O,"InChI=1S/C15H14N4O2/c1-8-11(20)7-17-14-12(8)18-15(21)10-3-2-6-16-13(10)19(14)9-4-5-9/h2-3,6-7,9,20H,4-5H2,1H3,(H,18,21)",DANIONWINZEYME-UHFFFAOYSA-N
SMP0000642,Nevirapine Metabolism Pathway,Drug Metabolism,PW_C008648,8-Hydroxynevirapine,HMDB0013913,,,"","",C15H14N4O2,"2-cyclopropyl-13-hydroxy-7-methyl-2,4,9,15-tetraazatricyclo[9.4.0.0³,⁸]pentadeca-1(11),3,5,7,12,14-hexaen-10-one",CC1=C2NC(=O)C3=C(N=CC(O)=C3)N(C3CC3)C2=NC=C1,"InChI=1S/C15H14N4O2/c1-8-4-5-16-14-12(8)18-15(21)11-6-10(20)7-17-13(11)19(14)9-2-3-9/h4-7,9,20H,2-3H2,1H3,(H,18,21)",DZPVEPLRIKDBFC-UHFFFAOYSA-N
SMP0000642,Nevirapine Metabolism Pathway,Drug Metabolism,PW_C008647,2-Hydroxynevirapine,HMDB0013912,,,"","",C15H14N4O2,"2-cyclopropyl-5-hydroxy-7-methyl-2,4,9,15-tetraazatricyclo[9.4.0.0³,⁸]pentadeca-1(11),3,5,7,12,14-hexaen-10-one",CC1=C2NC(=O)C3=C(N=CC=C3)N(C3CC3)C2=NC(O)=C1,"InChI=1S/C15H14N4O2/c1-8-7-11(20)17-14-12(8)18-15(21)10-3-2-6-16-13(10)19(14)9-4-5-9/h2-3,6-7,9H,4-5H2,1H3,(H,17,20)(H,18,21)",LFZSOJABLBVGRJ-UHFFFAOYSA-N
SMP0000642,Nevirapine Metabolism Pathway,Drug Metabolism,PW_C008646,12-Hydroxynevirapine,HMDB0013911,,155605,"","",C15H14N4O2,"2-cyclopropyl-7-(hydroxymethyl)-2,4,9,15-tetraazatricyclo[9.4.0.0³,⁸]pentadeca-1(11),3,5,7,12,14-hexaen-10-one",OCC1=C2NC(=O)C3=C(N=CC=C3)N(C3CC3)C2=NC=C1,"InChI=1S/C15H14N4O2/c20-8-9-5-7-17-14-12(9)18-15(21)11-2-1-6-16-13(11)19(14)10-3-4-10/h1-2,5-7,10,20H,3-4,8H2,(H,18,21)",SEBABOMFNCVZGF-UHFFFAOYSA-N
SMP0000642,Nevirapine Metabolism Pathway,Drug Metabolism,PW_C040608,3-Hydroxynevirapine glucuronide,HMDB0060743,,,,,C21H22N4O8,"(2S,3S,4S,5R)-6-({2-cyclopropyl-6-hydroxy-7-methyl-2,4,9,15-tetraazatricyclo[9.4.0.0³,⁸]pentadeca-1(11),3,5,7,9,12,14-heptaen-10-yl}oxy)-3,4,5-trihydroxyoxane-2-carboxylic acid",CC1=C2N=C(OC3O[C@@H]([C@@H](O)[C@H](O)[C@H]3O)C(O)=O)C3=C(N=CC=C3)N(C3CC3)C2=NC=C1O,"InChI=1S/C21H22N4O8/c1-8-11(26)7-23-18-12(8)24-19(10-3-2-6-22-17(10)25(18)9-4-5-9)33-21-15(29)13(27)14(28)16(32-21)20(30)31/h2-3,6-7,9,13-16,21,26-29H,4-5H2,1H3,(H,30,31)/t13-,14-,15+,16-,21?/m0/s1",GDAAYOYNGMRKSI-IQSUWLOCSA-N
SMP0000642,Nevirapine Metabolism Pathway,Drug Metabolism,PW_C040610,8-Hydroxynevirapine glucuronide,HMDB0061130,,,,,C21H22N4O8,"(2R,3R,4R,5S,6R)-6-({2-cyclopropyl-7-methyl-10-oxo-2,4,9,15-tetraazatricyclo[9.4.0.0³,⁸]pentadeca-1(11),3(8),4,6,12,14-hexaen-13-yl}oxy)-3,4,5-trihydroxyoxane-2-carboxylic acid",CC1=CC=NC2=C1NC(=O)C1=C(N=CC(O[C@H]3O[C@H]([C@H](O)[C@@H](O)[C@@H]3O)C(O)=O)=C1)N2C1CC1,"InChI=1S/C21H22N4O8/c1-8-4-5-22-18-12(8)24-19(29)11-6-10(7-23-17(11)25(18)9-2-3-9)32-21-15(28)13(26)14(27)16(33-21)20(30)31/h4-7,9,13-16,21,26-28H,2-3H2,1H3,(H,24,29)(H,30,31)/t13-,14-,15+,16-,21+/m1/s1",IVZWGLRSSHUFTI-WCYOCWRHSA-N
SMP0000642,Nevirapine Metabolism Pathway,Drug Metabolism,PW_C040607,2-Hydroxynevirapine glucuronide,HMDB0060720,,,,,C21H22N4O8,"(2S,3S,4S,5R,6S)-6-({2-cyclopropyl-10-hydroxy-7-methyl-2,4,9,15-tetraazatricyclo[9.4.0.0³,⁸]pentadeca-1(11),3(8),4,6,9,12,14-heptaen-5-yl}oxy)-3,4,5-trihydroxyoxane-2-carboxylic acid",CC1=CC(O[C@@H]2O[C@@H]([C@@H](O)[C@H](O)[C@H]2O)C(O)=O)=NC2=C1N=C(O)C1=C(N=CC=C1)N2C1CC1,"InChI=1S/C21H22N4O8/c1-8-7-11(32-21-15(28)13(26)14(27)16(33-21)20(30)31)23-18-12(8)24-19(29)10-3-2-6-22-17(10)25(18)9-4-5-9/h2-3,6-7,9,13-16,21,26-28H,4-5H2,1H3,(H,24,29)(H,30,31)/t13-,14-,15+,16-,21+/m0/s1",RNMZKTLILDCQOC-KUSYAZKWSA-N
SMP0000642,Nevirapine Metabolism Pathway,Drug Metabolism,PW_C040606,12-Hydroxynevirapine glucuronide,HMDB0060705,,,,,C21H22N4O8,"(2S,3S,4S,5R)-3,4,5-trihydroxy-6-{[2-(2-hydroxycyclopropyl)-7-methyl-2,4,9,15-tetraazatricyclo[9.4.0.0³,⁸]pentadeca-1(11),3,5,7,9,12,14-heptaen-10-yl]oxy}oxane-2-carboxylic acid",CC1=C2N=C(OC3O[C@@H]([C@@H](O)[C@H](O)[C@H]3O)C(O)=O)C3=C(N=CC=C3)N(C3CC3O)C2=NC=C1,"InChI=1S/C21H22N4O8/c1-8-4-6-23-18-12(8)24-19(9-3-2-5-22-17(9)25(18)10-7-11(10)26)33-21-15(29)13(27)14(28)16(32-21)20(30)31/h2-6,10-11,13-16,21,26-29H,7H2,1H3,(H,30,31)/t10?,11?,13-,14-,15+,16-,21?/m0/s1",UVZMQJUCOZEMQZ-RDPCRGLVSA-N
SMP0000642,Nevirapine Metabolism Pathway,Drug Metabolism,PW_C001065,Oxygen,HMDB0001377,C00007,15379,,7782-44-7,O2,oxidanone,O=O,InChI=1S/O2/c1-2,MYMOFIZGZYHOMD-UHFFFAOYSA-N
SMP0000642,Nevirapine Metabolism Pathway,Drug Metabolism,PW_C000146,NADPH,HMDB0000221,C00005,16474,"",53-57-6,C21H30N7O17P3,"{[(2S,3S,4S,5S)-2-(6-amino-9H-purin-9-yl)-5-[({[({[(2S,3R,4S,5S)-5-(3-carbamoyl-1,4-dihydropyridin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)methyl]-4-hydroxyoxolan-3-yl]oxy}phosphonic acid",NC(=O)C1=CN(C=CC1)[C@H]1O[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2O[C@@H]([C@@H](OP(O)(O)=O)[C@H]2O)N2C=NC3=C(N)N=CN=C23)[C@H](O)[C@@H]1O,"InChI=1S/C21H30N7O17P3/c22-17-12-19(25-7-24-17)28(8-26-12)21-16(44-46(33,34)35)14(30)11(43-21)6-41-48(38,39)45-47(36,37)40-5-10-13(29)15(31)20(42-10)27-3-1-2-9(4-27)18(23)32/h1,3-4,7-8,10-11,13-16,20-21,29-31H,2,5-6H2,(H2,23,32)(H,36,37)(H,38,39)(H2,22,24,25)(H2,33,34,35)/t10-,11-,13-,14-,15-,16-,20-,21-/m0/s1",ACFIXJIJDZMPPO-NCHANQSKSA-N
SMP0000642,Nevirapine Metabolism Pathway,Drug Metabolism,PW_C040034,Hydrogen Ion,HMDB0059597,C00080,15378,,,H,hydron,[H+],InChI=1S/p+1,GPRLSGONYQIRFK-UHFFFAOYSA-N
SMP0000642,Nevirapine Metabolism Pathway,Drug Metabolism,PW_C001420,Water,HMDB0002111,C00001,15377,,7732-18-5,H2O,water,O,InChI=1S/H2O/h1H2,XLYOFNOQVPJJNP-UHFFFAOYSA-N
SMP0000642,Nevirapine Metabolism Pathway,Drug Metabolism,PW_C000143,NADP,HMDB0000217,C00006,18009,,53-59-8,C21H29N7O17P3,"1-[(2R,3R,4S,5R)-5-[({[({[(2R,3R,4R,5R)-5-(6-amino-9H-purin-9-yl)-3-hydroxy-4-(phosphonooxy)oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)methyl]-3,4-dihydroxyoxolan-2-yl]-3-carbamoyl-1λ⁵-pyridin-1-ylium",NC(=O)C1=C[N+](=CC=C1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](OP(O)(O)=O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O,"InChI=1S/C21H28N7O17P3/c22-17-12-19(25-7-24-17)28(8-26-12)21-16(44-46(33,34)35)14(30)11(43-21)6-41-48(38,39)45-47(36,37)40-5-10-13(29)15(31)20(42-10)27-3-1-2-9(4-27)18(23)32/h1-4,7-8,10-11,13-16,20-21,29-31H,5-6H2,(H7-,22,23,24,25,32,33,34,35,36,37,38,39)/p+1/t10-,11-,13-,14-,15-,16-,20-,21-/m1/s1",XJLXINKUBYWONI-NNYOXOHSSA-O
SMP0000642,Nevirapine Metabolism Pathway,Drug Metabolism,PW_C001799,Heme,HMDB0003178,C00032,17627,DB02577,14875-96-8,C34H32FeN4O4,"(1R)-15,19-bis(2-carboxyethyl)-5,10-diethenyl-4,9,14,20-tetramethyl-2λ⁵,22,23λ⁵,25-tetraaza-1-ferraoctacyclo[11.9.1.1¹,⁸.1³,²¹.0²,⁶.0¹⁶,²³.0¹⁸,²².0¹¹,²⁵]pentacosa-2,4,6,8,10,12,14,16(23),17,19,21(24)-undecaene-2,23-bis(ylium)",CC1=C(CCC(O)=O)C2=CC3=[N+]4C(=CC5=C(C=C)C(C)=C6C=C7C(C=C)=C(C)C8=[N+]7[Fe@]4(N2C1=C8)N56)C(C)=C3CCC(O)=O,"InChI=1S/C34H34N4O4.Fe/c1-7-21-17(3)25-13-26-19(5)23(9-11-33(39)40)31(37-26)16-32-24(10-12-34(41)42)20(6)28(38-32)15-30-22(8-2)18(4)27(36-30)14-29(21)35-25;/h7-8,13-16H,1-2,9-12H2,3-6H3,(H4,35,36,37,38,39,40,41,42);/q;+4/p-2/b25-13-,26-13-,27-14-,28-15-,29-14-,30-15-,31-16-,32-16-;",YHLKGEDAGPGZPN-RGGAHWMASA-L
SMP0000642,Nevirapine Metabolism Pathway,Drug Metabolism,PW_C000746,Uridine diphosphate glucuronic acid,HMDB0000935,C00167,17200,,2616-64-0,C15H22N2O18P2,"(2S,3S,4S,5R,6R)-6-({[({[(2R,3S,4R,5R)-5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)-3,4,5-trihydroxyoxane-2-carboxylic acid",O[C@@H]1[C@@H](COP(O)(=O)OP(O)(=O)O[C@H]2O[C@@H]([C@@H](O)[C@H](O)[C@H]2O)C(O)=O)O[C@H]([C@@H]1O)N1C=CC(=O)NC1=O,"InChI=1S/C15H22N2O18P2/c18-5-1-2-17(15(26)16-5)12-9(22)6(19)4(32-12)3-31-36(27,28)35-37(29,30)34-14-10(23)7(20)8(21)11(33-14)13(24)25/h1-2,4,6-12,14,19-23H,3H2,(H,24,25)(H,27,28)(H,29,30)(H,16,18,26)/t4-,6-,7+,8+,9-,10-,11+,12-,14-/m1/s1",HDYANYHVCAPMJV-LXQIFKJMSA-N
SMP0000642,Nevirapine Metabolism Pathway,Drug Metabolism,PW_C000201,Uridine 5'-diphosphate,HMDB0000295,C00015,17659,DB03435,58-98-0,C9H14N2O12P2,"[({[(2R,3S,4R,5R)-5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]phosphonic acid",O[C@H]1[C@@H](O)[C@@H](O[C@@H]1COP(O)(=O)OP(O)(O)=O)N1C=CC(=O)NC1=O,"InChI=1S/C9H14N2O12P2/c12-5-1-2-11(9(15)10-5)8-7(14)6(13)4(22-8)3-21-25(19,20)23-24(16,17)18/h1-2,4,6-8,13-14H,3H2,(H,19,20)(H,10,12,15)(H2,16,17,18)/t4-,6-,7-,8-/m1/s1",XCCTYIAWTASOJW-XVFCMESISA-N
SMP0000642,Nevirapine Metabolism Pathway,Drug Metabolism,PW_C040609,4-Carboxynevirapine,HMDB0060759,,,"","",C15H12N4O3,"2-cyclopropyl-10-oxo-2,4,9,15-tetraazatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3(8),4,6,11,13-hexaene-7-carboxylic acid",OC(=O)C1=CC=NC2=C1NC(=O)C1=CC=CN=C1N2C1CC1,"InChI=1S/C15H12N4O3/c20-14-10-2-1-6-16-12(10)19(8-3-4-8)13-11(18-14)9(15(21)22)5-7-17-13/h1-2,5-8H,3-4H2,(H,18,20)(H,21,22)",WDXCMIDQWGYHIN-UHFFFAOYSA-N
SMP0000642,Nevirapine Metabolism Pathway,Drug Metabolism,PW_C001783,Hydrogen peroxide,HMDB0003125,C00027,16240,,7722-84-1,H2O2,peroxol,OO,InChI=1S/H2O2/c1-2/h1-2H,MHAJPDPJQMAIIY-UHFFFAOYSA-N
SMP0000642,Nevirapine Metabolism Pathway,Drug Metabolism,PW_C000414,Adenosine triphosphate,HMDB0000538,C00002,15422,DB00171,56-65-5,C10H16N5O13P3,"({[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)phosphonic acid",NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O,"InChI=1S/C10H16N5O13P3/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(26-10)1-25-30(21,22)28-31(23,24)27-29(18,19)20/h2-4,6-7,10,16-17H,1H2,(H,21,22)(H,23,24)(H2,11,12,13)(H2,18,19,20)/t4-,6-,7-,10-/m1/s1",ZKHQWZAMYRWXGA-KQYNXXCUSA-N
SMP0000642,Nevirapine Metabolism Pathway,Drug Metabolism,PW_C001034,Adenosine diphosphate,HMDB0001341,C00008,16761,,58-64-0,C10H15N5O10P2,"[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]phosphonic acid",NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O,"InChI=1S/C10H15N5O10P2/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(24-10)1-23-27(21,22)25-26(18,19)20/h2-4,6-7,10,16-17H,1H2,(H,21,22)(H2,11,12,13)(H2,18,19,20)/t4-,6-,7-,10-/m1/s1",XTWYTFMLZFPYCI-KQYNXXCUSA-N
SMP0000642,Nevirapine Metabolism Pathway,Drug Metabolism,PW_C001104,Phosphate,HMDB0001429,C00009,18367,"",14265-44-2,O4P,phosphate,[O-]P([O-])([O-])=O,"InChI=1S/H3O4P/c1-5(2,3)4/h(H3,1,2,3,4)/p-3",NBIIXXVUZAFLBC-UHFFFAOYSA-K
